Latest from Pharmaceuticals

Up in Smoke: Why NZ's medical cannabis industry is struggling to make ends meet
After tragic cases, a new industry touted as a potential saviour has run into roadblocks.

Pharmac culture review finds 'reset' needed, staff doubt it's possible
Sarah Fitt resigned as Pharmac chief executive earlier this year.

Salmon given antianxiety drugs take more risks, study finds
Young salmon in central Sweden must endure a gauntlet to migrate to the Baltic.

Door opened to microchip, pharma tariffs, Trump hints at auto tariff pause
Tesla, other automaker stocks rise after White House comments.

Cecilia Robinson: Why extending prescriptions to 12 months will be a good thing
OPINION: Extending prescriptions to 12 months will free up resources.

Fitt resigns as Pharmac chief executive, Bennett expects major change to culture
Drug-buying agency's chief executive had received criticism in the role.

Trump car tariff threat puts pressure on stock markets
Global stocks were under pressure after Trump broadened his tariff threats.

Class action targets ‘ineffective’ cold medicines
Law firm files action against Johnson & Johnson.

‘Promising’: Ozempic may protect against Alzheimer’s
New York Times: Could the drugs that upended diabetes and obesity benefit the brain?

‘Phenomenal’ teen cheerleader died of meningitis a week after starting dream job
'She got to live her dream for one week. It was so unfairly taken from her.'

Dow rises, Nasdaq falls ahead of earnings, inflation data
Markets have swagger ahead of economic releases on US inflation and retail sales.

‘Ozempic face’ and Baby Boomers drive injectables craze
Financial Times: 'Facial sagging' worries drive people to injectable aesthetic treatments.

Letters: Common sense needed over use of police resources
OPINION: Police need to 'hunt where the ducks are'.

Pharmac minister, chair refuse to express confidence in CEO Sarah Fitt
The revelation came amid a scrappy start to Parliament's second scrutiny week.

Could Pharmac’s ADHD medication changes be a game-changer or a risk?
A new medicine and simplified renewal criteria for those with ADHD.

Women 'blindsided' by Pharmac's hormone replacement switch
Pharmac plans to switch to the Mylan brand of estradiol transdermal patches next year.

Biotechs test IPO market despite concerns over RFK jnr's health role
Financial Times: Trump nominee has caused some concern over medicine spending cuts.

'Her legacy': Auckland mum dies as cancer drug is funded
Adrienne Smithson spent her last months fighting for wider access to the medication.

'Huge step forward' for Kiwi women as Pharmac funds new menopause drug
The announcement comes amid a global shortage of transdermal oestrogen patches.

Depression can affect sex drive. Here’s how to cope.
While some antidepressants affect libido, others can help restore sexual function.

Opinion: The forgotten cancer – lives at stake as we wait for Govt action
OPINION: More than 21,000 Kiwis are living with a blood cancer.